ChangeGradients for Adolescent Health Behaviors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new interactive system called ChangeGradients, designed to help adolescents make healthier choices, particularly concerning alcohol use. The system uses personalized stories and feedback to guide teens toward better health habits. Participants will use this system at home for four weeks following an initial introduction during their clinic visit. Teens who use alcohol and visit certain UCSF clinics for a well-visit might be suitable candidates. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative research that could shape future health interventions for adolescents.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this health behavior change system is safe for adolescents?
Research shows that specific safety information for the ChangeGradients treatment is not yet available. This project uses virtual, interactive stories and a type of computer learning to help change behaviors in teenagers, particularly regarding alcohol use. Since it is neither a drug nor a medical procedure, the safety risks are likely low.
The study's "Not Applicable" phase label indicates it is still in the early research stages, suggesting limited safety data. However, because it involves a computer program, the risks are generally lower compared to traditional medical treatments.
Prospective participants should ask the research team about any possible risks or concerns.12345Why are researchers excited about this trial?
Unlike traditional treatments for adolescent health behaviors, which often rely on direct counseling or medication, ChangeGradients takes a novel approach by using interactive narratives delivered through personal devices like laptops or tablets. This method allows for a personalized and engaging experience, accessible from home, which could increase engagement and adherence among teenagers. Researchers are excited about this digital, story-based intervention because it can seamlessly integrate into daily life, potentially leading to more lasting behavior changes without the need for frequent clinic visits.
What evidence suggests that the ChangeGradients system is effective for adolescent health behavior change?
Research shows that the ChangeGradients system, which participants in this trial may receive, is designed to help teenagers reduce risky behaviors, especially drinking alcohol. It uses a type of computer learning to create personalized stories that adapt based on user responses. This method helps teenagers understand the consequences of their actions and make better choices. Although specific results for ChangeGradients are not yet available, the technology relies on proven methods that help people change behaviors by providing personalized feedback and support.23467
Who Is on the Research Team?
Elizabeth M Ozer, PhD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for English-speaking adolescents aged 15-17 who visit UCSF Pediatric primary care clinics for a regular check-up and report current alcohol use. It's focused on those interested in changing risky behaviors, especially related to alcohol consumption.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Adolescents interact with the CHANGEGRADIENTS system to develop an experiential understanding of alcohol use decisions and behavior change
Follow-up
Participants are monitored for changes in self-efficacy and alcohol use behavior
Quality of Care Assessment
Assessment of the quality of care delivered to adolescents using the Adolescent Report of the Visit (AROV)
What Are the Treatments Tested in This Trial?
Interventions
- ChangeGradients
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
North Carolina State University
Collaborator